Status:
UNKNOWN
Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Schizophrenia
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
Amantadine as add-on therapy to antipsychotics may improve schizophrenia positive, negative and cognitive symptoms.
Eligibility Criteria
Inclusion
- Under antipsychotics with residual symptoms
Exclusion
- Pregnancy
- Lactation
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00999505
Start Date
May 1 2010
End Date
September 1 2011
Last Update
February 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903